Fritextsökning
Innehållstyper
-
Nytt namn i Symphogens ledning
Adriann Sax har utsetts till affärschef på det danska företaget.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Få överraskningar i rapporten
Pledpharmas kvartalsrapport bjöd inte på några stora nyheter men planerna på diskussioner med FDA och potentiella samarbetspartners ligger fast.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Smarta män tar sin medicin
Generell kognitiv förmåga har visat sig spela roll för hur väl män tar sin ordinerade medicin efter en hjärtinfarkt. Det visar en ny studie från Umeå och Uppsala universitet.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Raysearch igång i Kina
Första patienten ombord i strålstudie.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Släpper aptitretande rapport
Stockholm Business Region släpper rapport om onkologi för att locka investerare till Stockholm-Uppsalaregionen. – Rapporten ska vara en aptitretare, förklarar Ylva Hultman.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Planerar det regulatoriska arbetet
Anna Törner från SDS ska stötta Lidds med den regulatoriska planen för bolagets läkemedelskandidat mot prostatacancer, där en fas IIb-studie är på gång.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
Aprea sparkar igång studie
Första patienten doserad i fas Ib/II-studien med cancerbehandlingen APR-246.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Stöd till kvinnliga forskare
17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.